"At UCSF Health, we're taking every precaution to keep you safe and healthy during the COVID-19 pandemic. For our outpatients, we offer video visits and virtual care for hundreds of conditions as well as for primary care, mental health services, medication monitoring and more. In our hospitals, we test every patient admitted and before most procedures. Our staff wears face masks and practices rigorous hand hygiene, as well as many other methods of infection prevention. Before entering your room, they'll make sure you're masked and (in UCSF Benioff Children's Hospitals) that your child age 2+ is masked. If you're planning to visit someone in the hospital, be sure to check our COVID-19 visitor restrictions before going."

During the past decade, University of California, San Francisco - Division of Neuro-Oncology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University of California, San Francisco - Division of Neuro-Oncology" are "Brain Cancer" (2 trials), "GBM" (2 trials), "Glioblastoma" (2 trials), "Glioblastoma Multiforme" (2 trials) and "Glioma" (2 trials). Many other conditions were trialed in "University of California, San Francisco - Division of Neuro-Oncology" in a lesser frequency.

Most popular intervention types in "University of California, San Francisco - Division of Neuro-Oncology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Physician's Choice of Salvage Therapy - carboplatin" (1 trials), "Physician's Choice of Salvage Therapy - lomustine" (1 trials), "Physician's Choice of Salvage Therapy - temozolomide" (1 trials), "VAL-083 (Dianhydrogalactitol)" (1 trials) and "VAL-083, Dianhydrogalactitol" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of California, San Francisco - Division of Neuro-Oncology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University of California, San Francisco - Division of Neuro-Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University of California, San Francisco - Division of Neuro-Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of California, San Francisco - Division of Neuro-Oncology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".